Mucin 1 promotes salivary gland cancer cell proliferation and metastasis by regulating the epidermal growth factor receptor signaling pathway

Seethala, 2017, Update from the 4th edition of the world health organization classification of head and neck tumours: tumors of the salivary gland, Head Neck Pathol, 11, 55, 10.1007/s12105-017-0795-0 Guzzo, 2010, Major and minor salivary gland tumors, Crit Rev Oncol Hematol, 74, 134, 10.1016/j.critrevonc.2009.10.004 Colevas, 2018, NCCN guidelines insights: head and neck cancers, version 1.2018, J Natl Compr Cancer Netw, 16, 479, 10.6004/jnccn.2018.0026 Nath, 2014, MUC1: a multifaceted oncoprotein with a key role in cancer progression, Trends Mol Med, 20, 332, 10.1016/j.molmed.2014.02.007 Kufe, 2009, Mucins in cancer: function, prognosis and therapy, Nat Rev Cancer, 9, 874, 10.1038/nrc2761 Kufe, 2013, MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches, Oncogene, 32, 1073, 10.1038/onc.2012.158 Huang, 2005, MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin, Cancer Res, 65, 10413, 10.1158/0008-5472.CAN-05-2474 Ren, 2004, Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents, Cancer Cell, 5, 163, 10.1016/S1535-6108(04)00020-0 Yin, 2004, MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress, J Biol Chem, 279, 45721, 10.1074/jbc.M408027200 Maeda, 2018, MUC1-C Induces PD-L1 and immune evasion in triple-negative breast cancer, Cancer Res, 78, 205, 10.1158/0008-5472.CAN-17-1636 Carlson, 2019, Salivary gland malignancies, Oral Maxillofac Surg Clin, 31, 125, 10.1016/j.coms.2018.08.007 Liu, 2014, MUC1 regulates cyclin D1 gene expression through p120 catenin and beta-catenin, Oncogenesis, 3, e107, 10.1038/oncsis.2014.19 Ahmad, 2009, MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor, Cancer Res, 69, 7013, 10.1158/0008-5472.CAN-09-0523 Roy, 2011, MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition, Oncogene, 30, 1449, 10.1038/onc.2010.526 Gnemmi, 2014, MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/beta-catenin pathway and interaction with SNAIL promoter, Cancer Lett, 346, 225, 10.1016/j.canlet.2013.12.029 Nath, 2014, MUC1: a multifaceted oncoprotein with a key role in cancer progression, Trends Mol Med, 20, 332, 10.1016/j.molmed.2014.02.007 Kimura, 2013, MUC1 immunotherapy is here to stay, Expet Opin Biol Ther, 13, 35, 10.1517/14712598.2012.725719 Schmelzer, 2020, Effects of mesenchymal stem cell coculture on human lung small airway epithelial cells, BioMed Res Int, 2020, 10.1155/2020/9847579 Creaney, 2008, Overexpression and altered glycosylation of MUC1 in malignant mesothelioma, Br J Cancer, 98, 1562, 10.1038/sj.bjc.6604340 Schroeder, 2001, Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland, J Biol Chem, 276, 13057, 10.1074/jbc.M011248200 Li, 2001, The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin, J Biol Chem, 276, 35239, 10.1074/jbc.C100359200 Mitsudomi, 2010, Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer, FEBS J, 277, 301, 10.1111/j.1742-4658.2009.07448.x Pochampalli, 2007, MUC1 is a novel regulator of ErbB1 receptor trafficking, Oncogene, 26, 1693, 10.1038/sj.onc.1209976 Bitler, 2010, MUC1 regulates nuclear localization and function of the epidermal growth factor receptor, J Cell Sci, 123, 1716, 10.1242/jcs.062661 Piyush, 2017, Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells, Cell Death Differ, 24, 1937, 10.1038/cdd.2017.119 Merlin, 2011, Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells, Oncogene, 30, 2514, 10.1038/onc.2010.631 Jiang, 2020, Evodiamine suppresses non-small cell lung cancer by elevating CD8 T cells and downregulating the MUC1-C/PD-L1 axis, J Exp Clin Cancer Res, 39, 249, 10.1186/s13046-020-01741-5 Bouillez, 2017, MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer, Oncogene, 36, 4037, 10.1038/onc.2017.47 Pyzer, 2017, MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs, Leukemia, 31, 2780, 10.1038/leu.2017.163 Bouillez, 2017, MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer, OncoImmunology, 6, 10.1080/2162402X.2017.1338998 Liu, 2018, Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect, Immunol Lett, 200, 33, 10.1016/j.imlet.2018.06.004 Chavez, 2015, Quantitative interactome analysis reveals a chemoresistant edgotype, Nat Commun, 6, 7928, 10.1038/ncomms8928 Jin, 2017, MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner, Cell Death Dis, 8, 10.1038/cddis.2017.378 Thulasiraman, 2016, Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells, Int J Oncol, 49, 479, 10.3892/ijo.2016.3534 Nath, 2013, MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes, Oncogenesis, 2, e51, 10.1038/oncsis.2013.16 Song, 2006, Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene, Cancer Chemother Pharmacol, 58, 776, 10.1007/s00280-006-0224-7 Shukla, 2017, MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer, Cancer Cell, 32, 392, 10.1016/j.ccell.2017.08.008 Chaika, 2012, MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer, Proc Natl Acad Sci U S A, 109, 13787, 10.1073/pnas.1203339109 Mehla, 2014, MUC1: a novel metabolic master regulator, Biochim Biophys Acta, 1845, 126